NEC’s artificial intelligence (AI) supports doctors to determine if colorectal lesions are potentially neoplastic
TOKYO, Jul 14, 2021 – (JCN Newswire via SEAPRWire.com) – NEC Corporation (NEC; TSE: 6701) announced today the development of an AI technology for supporting doctors in determining if colorectal lesions are neoplastic or non-neoplastic. NEC developed a new technology, called “Cx20,” while seeking to assist in the early detection of colorectal lesions. Cx20 has... » read more